World's Best Scientists 2026 revealed!
Award Badge
Immunology
Belgium
2026

D-Index & Metrics

Immunology

D-Index
109
Citations
38066
World Ranking
524
National Ranking
4

Medicine

D-Index
109
Citations
38425
World Ranking
5825
National Ranking
61

Research.com Recognitions

  • 2026 - Research.com Immunology in Belgium Leader Award
  • 2025 - Research.com Immunology in Belgium Leader Award
  • 2023 - Research.com Immunology in Belgium Leader Award
  • 2022 - Research.com Immunology in Belgium Leader Award

Overview

Michel Goldman is affiliated with the Université Libre de Bruxelles in Belgium and has an extensive research portfolio primarily in the field of medicine. Their work spans various subfields including infectious diseases, surgery, neurology, oncology, and molecular biology.

Their main research interests cover topics such as the long-term effects of COVID-19, lymphadenopathy diagnosis and analysis, COVID-19 clinical research studies, SARS-CoV-2 and COVID-19 research, inflammasome and immune disorders, lymphoma diagnosis and treatment, and heparin-induced thrombocytopenia and thrombosis.

Michel Goldman has published recent papers including:

  • "Autoantibodies and SARS-CoV2 infection: The spectrum from association to clinical implication: Report of the 15th Dresden Symposium on Autoantibodies" (2021, Autoimmunity Reviews)
  • "Rapid Progression of Angioimmunoblastic T Cell Lymphoma Following BNT162b2 mRNA Vaccine Booster Shot: A Case Report" (2021, Frontiers in Medicine)
  • "Thrombotic thrombocytopenia associated with COVID-19 infection or vaccination: Possible paths to platelet factor 4 autoimmunity" (2021, PLoS Medicine)
  • "Online Information on Probiotics: Does It Match Scientific Evidence?" (2020, Frontiers in Medicine)
  • "Long Covid, a great imitator of the 21th century" (2022, Frontiers in Medicine)

The scientist frequently collaborates with co-authors including Marie Neunez, Serge Goldman, Elie Cogan, Dominique Bron, and Thomas Tousseyn.

Michel Goldman's publications often appear in venues such as Frontiers in Medicine, SSRN Electronic Journal, Frontiers for Young Minds, Autoimmunity Reviews, and PLoS Medicine.

In addition to journal articles, Michel Goldman has authored a book titled Le coronavirus et ces microbes qu'il nous faut combattre, première édition, published by Frontiers Media in 2022.

Best Publications

  • Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes.

    Bart Keymeulen;Evy Vandemeulebroucke;Anette G. Ziegler;Chantal Mathieu

  • Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.

    C. Gérard;C Bruyns;Arnaud Marchant;Daniel Abramowicz

  • Development of a cross-platform biomarker signature to detect renal transplant tolerance in humans

    Pervinder Sagoo;Esperanza Perucha;Birgit Sawitzki;Stefan Tomiuk

  • Interleukin-10 inhibits B7 and intercellular adhesion molecule-1 expression on human monocytes

    Fabienne Willems;Arnaud Marchant;Jean-Pierre Delville;Catherine Gérard

  • Interleukin-10 production during septicaemia

    A. Marchant;M. Goldman;J. Devière;B. Byl

  • Bacterial lipopolysaccharide stimulates the production of cytokines and the expression of costimulatory molecules by human peripheral blood dendritic cells: evidence for a soluble CD14-dependent pathway.

    Valérie Verhasselt;Christel Buelens;Fabienne Willems;Donat De Groote

  • Release of tumor necrosis factor, interleukin-2, and gamma-interferon in serum after injection of OKT3 monoclonal antibody in kidney transplant recipients.

    Daniel Abramowicz;Liliane Schandene;Michel Goldman;Alain Crusiaux

  • TH2 cells in systemic autoimmunity: insights from allogeneic diseases and chemically-induced autoimmunity.

    Michel Goldman;Philippe Druet;Ernst Gleichmann

  • Role of interleukin-4 and interleukin-10 in murine collagen-induced arthritis. Protective effect of interleukin-4 and interleukin-10 treatment on cartilage destruction.

    L. A. B. Joosten;E. Lubberts;P. Durez;M. M. A. Helsen

  • Vaccination and autoimmune disease: what is the evidence?

    David C Wraith;Michel Goldman;Paul-Henri Lambert

  • Brief report: Clonal proliferation of type 2 helper T cells in a man with the hypereosinophilic syndrome

    Elie Cogan;Liliane Schandene;Alain Crusiaux;Pascale Cochaux

  • IL-10 Is an Important Mediator of the Enhanced Susceptibility to Pneumococcal Pneumonia after Influenza Infection

    Koenraad F. van der Sluijs;Leontine J. R. van Elden;Monique Nijhuis;Rob Schuurman

  • Deficient IL-12(p35) Gene Expression by Dendritic Cells Derived from Neonatal Monocytes

    Stanislas Goriely;Benoı̂t Vincart;Patrick Stordeur;Johan Vekemans

  • Interleukin-10 differentially regulates B7-1 (CD80) and B7-2 (CD86) expression on human peripheral blood dendritic cells.

    Christel Buelens;Fabienne Willems;Anne Delvaux;Géraldine Pierard

  • Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion.

    S Dubucquoi;P Desreumaux;A Janin;O Klein

  • Interleukin-10 controls interferon-gamma and tumor necrosis factor production during experimental endotoxemia.

    Arnaud Marchant;Catherine Bruyns;Peter Vandenabeele;Martine Ducarme

  • Fluorouracil and recombinant alfa-2a-interferon: an active regimen against advanced colorectal carcinoma.

    S Wadler;E L Schwartz;M Goldman;A Lyver

  • Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation, and liver fibrosis induced by carbon tetrachloride in mice

    Hubert Louis;Jean-Luc Van Laethem;Wei Wu;Eric Quertinmont

  • Interleukin-10 prevents the generation of dendritic cells from human peripheral blood mononuclear cells cultured with interleukin-4 and granulocyte/macrophage-colony-stimulating factor

    Christel Buelens;Valérie Verhasselt;Donat De Groote;Kris M. Thielemans

  • B7/CD28-dependent IL-5 production by human resting T cells is inhibited by IL-10.

    Liliane Schandené;Cristina Alonso-Vega;Fabienne Willems;C. Gérard

  • Interleukin-10: actions and therapeutic potential.

    Michel Goldman;Thierry Velu;Marina Pretolani

Frequent Co-Authors

Fabienne Willems
Fabienne Willems Université Libre de Bruxelles
Arnaud Marchant
Arnaud Marchant Université Libre de Bruxelles
Stanislas Goriely
Stanislas Goriely Université Libre de Bruxelles
Oberdan Leo
Oberdan Leo Université Libre de Bruxelles
Peter Vandenabeele
Peter Vandenabeele Ghent University
Paul-Henri Lambert
Paul-Henri Lambert University of Geneva
Sandrine Florquin
Sandrine Florquin University of Amsterdam
Kris Thielemans
Kris Thielemans Vrije Universiteit Brussel
Maria-Luisa Alegre
Maria-Luisa Alegre University of Chicago
Muriel Moser
Muriel Moser Université Libre de Bruxelles

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Immunology in the USA opens doors to various related healthcare careers, many of which can be enhanced through online education. For those interested in nursing but coming from non-nursing backgrounds, 12-month accelerated nursing programs online for non nurses provide an excellent pathway to transition quickly into the nursing field while building a strong foundation in patient care and immune system health.

If you're seeking a faster route into registered nursing, exploring 12-month accelerated nursing programs can be beneficial. These programs cater to driven students aiming for rapid completion without compromising essential clinical training relevant to immunology applications.

For those interested in practical nursing roles, easy lpn programs to get into offer accessible entry points. Licensed Practical Nurses often work alongside immunologists in clinical settings, making it a viable pathway to support and understand immune-related healthcare.

Advancing further, easiest nurse practitioner degree programs provide options to gain advanced practice credentials, enabling direct patient diagnosis and treatment in immunology-focused specialties. This pathway is ideal for those looking to deepen their impact on patient immune health.

Best Scientists Citing Michel Goldman

Trending Scientists